MedTrace Logo

The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence

NCT00434876 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2013-08-09

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to determine how efficacy of quetiapine (seroquel XR) in improving the sleep in recovering alcohol dependent subjects.

Conditions

  • Alcoholism
  • Sleep Initiation and Maintenance Disorders

Interventions

DRUG

Quetiapine XR

Quetiapine is a second generation antipsychotic medication, which has also recently shown to be associated with properties of mood stabilization in bipolar disorder.

DRUG

Placebo.

Inactive or inert pill which will be used as a comparator.

Sponsors & Collaborators

  • Subhajit Chakravorty

    lead FED

Principal Investigators

  • Subhajit Chakravorty, MD · Philadelphia, OPC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-11-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00434876 on ClinicalTrials.gov